References
- Prevalence of rare diseases: bibliographic data [Internet]. Orphanet Report Series, Rare Diseases collection, January 2021, Number 1: Diseases listed in alphabetical order; 2021. Available from: https://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed 9 Mar 2021.
- Haack TB, Hogarth P, Kruer MC, et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, x-linked dominant form of NBIA. Am J Hum Genet [Internet]. 2012 Dec 7;91(6):1144–1149. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23176820. Accessed 4 Dec 2020.
- Saitsu H, Nishimura T, Muramatsu K, et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet [Internet]. 2013;45(4):445–449,449e1. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23435086. Accessed 4 Dec 2020.
- Wan H, Wang Q, Chen X, et al. WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death. Autophagy [Internet]. 2020 Mar;16(3):531–547. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31204559. Accessed 17 Feb 2021.
- Ji C, Zhao H, Chen D, et al. Beta-propeller proteins WDR45 and WDR45B regulate autophagosome maturation into autolysosomes in neural cells. Curr Biol [Internet]. 2021 Feb;31(8)1666–1677.e6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33636118. Accessed 1 Mar 2021.
- Cong Y, So V, Tijssen MAJ, et al. WDR45, one gene associated with multiple neurodevelopmental disorders. Autophagy [Internet]. 2021 Apr 12:1–16. doi:https://doi.org/10.1080/15548627.2021.1899669. Accessed 15 Apr 2021.
- Adang LA, Pizzino A, Malhotra A, et al. Phenotypic and imaging spectrum associated with WDR45. Pediatr Neurol [Internet]. 2020 Aug;109:56–62. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32387008. Accessed 4 Dec 2020.
- Garbade SF, Zielonka M, Komatsuzaki S, et al. Quantitative retrospective natural history modeling for orphan drug development. J Inherit Metab Dis [Internet]. 2020 Aug 26. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32845020. Accessed 4 Dec 2020
- Hamdan FF, Srour M, Capo-Chichi JM, et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet [Internet]. 2014 Oct;10(10):e1004772. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25356899. Accessed 23 Feb 2021.
- Carvill GL, Liu A, Mandelstam S, et al. Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45. Epilepsia [Internet]. 2018 Jan;59(1):e5–e13. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29171013. Accessed 23 Feb 2021.
- Krey I, Krois-Neudenberger J, Hentschel J, et al. Genotype-phenotype correlation on 45 individuals with west syndrome. Eur J Paediatr Neurol [Internet]. 2020 Mar;25:134–138. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31791873. Accessed 23 Feb 2021.
- Kohler S, Carmody L, Vasilevsky N, et al. Expansion of the human phenotype ontology (HPO) knowledge base and resources. Nucleic Acids Res [Internet]. 2019 Jan 8;47(D1):D1018–D1027. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30476213. Accessed 7 Dec 2020.
- Robinson PN, Kohler S, Bauer S, et al. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet [Internet]. 2008 Nov;83(5):610–615. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18950739. Accessed 7 Dec 2020.
- Seibler P, Burbulla LF, Dulovic M, et al. Iron overload is accompanied by mitochondrial and lysosomal dysfunction in WDR45 mutant cells. Brain [Internet]. 2018 Oct 1;141(10):3052–3064. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30169597. Accessed 17 Feb 2021.
- Ebrahimi-Fakhari D, Saffari A, Wahlster L, et al. Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism. Brain [Internet]. 2016 Feb;139(2):317–337. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26715604. Accessed 23 Feb 2021.
- Chard M, Appendino JP, Bello-Espinosa LE, et al. Single-center experience with beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum. Mol Genet Metab Rep [Internet]. 2019 Sep;20:100483. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31293896. Accessed 3 Mar 2021.
- Hinarejos I, Machuca-Arellano C, Sancho P, et al. Mitochondrial dysfunction, oxidative stress and neuroinflammation in neurodegeneration with brain iron accumulation (NBIA). Antioxidants (Basel) [Internet]. 2020 Oct 20;9(10). Available from: https://www.ncbi.nlm.nih.gov/pubmed/33092153. Accessed 17 Feb 2021.
- Hayflick SJ, Hogarth P. As iron goes, so goes disease? Haematologica [Internet]. 2011 Nov;96(11):1571–1572. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22058278. Accessed 15 Feb 2021.
- Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci [Internet]. 2013 Aug;14(8):551–564. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23820773. Accessed 17 Feb 2021.
- Huebl J, Schneider SA. Iron chelation in pantothenate kinase-associated neurodegeneration: a possible new avenue for slowing down disease progression in neurodegeneration. Mov Disord [Internet]. 2019 Oct;34(10):1476–1477. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31483532. Accessed 15 Feb 2021.
- Klopstock T, Tricta F, Neumayr L, et al. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol [Internet]. 2019 Jul;18(7):631–642. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31202468. Accessed 15 Feb 2021.
- Lim SY, Tan AH, Ahmad-Annuar A, et al. A patient with beta-propeller protein-associated neurodegeneration: treatment with iron chelation therapy. J Mov Disord [Internet]. 2018 May;11(2):89–92. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29860786. Accessed 2 Mar 2021.
- Fonderico M, Laudisi M, Andreasi NG, et al. Patient affected by beta-propeller protein-associated neurodegeneration: a therapeutic attempt with iron chelation therapy. Front Neurol [Internet]. 2017;8:385. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28878728. Accessed 15 Feb 2021.
- Zarate YA, Jones JR, Jones Ma, et al. Lessons from a pair of siblings with BPAN. Eur J Hum Genet [Internet]. 2016 Jul;24(7):1080–1083. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26577041. Accessed 5 Feb 2021.
- Nakashima M, Takano K, Tsuyusaki Y, et al. WDR45 mutations in three male patients with west syndrome. J Hum Genet [Internet]. 2016 Jul;61(7):653–661. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27030146. Accessed 5 Feb 2021.
- Abidi A, Mignon-Ravix C, Cacciagli P, et al. Early-onset epileptic encephalopathy as the initial clinical presentation of WDR45 deletion in a male patient. Eur J Hum Genet [Internet]. 2016 Apr;24(4):615–618. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26173968. Accessed 4 Dec 2020.
- Kerr JS, Adriaanse BA, Greig NH, et al. Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci [Internet]. 2017 Mar;40(3):151–166. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28190529. Accessed 23 Feb 2021.
- Karabiyik C, Lee MJ, Rubinsztein DC. Autophagy impairment in Parkinson’s disease. Essays Biochem [Internet]. 2017 Dec 12;61(6):711–720. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29233880. Accessed 23 Feb 2021.
- Ramesh N, Pandey UB. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol Neurosci [Internet]. 2017;10:263. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28878620. Accessed 23 Feb 2021.
- Kaliszewski M, Knott AB, Bossy-Wetzel E. Primary cilia and autophagic dysfunction in huntington’s disease. Cell Death Differ [Internet]. 2015 Sep;22(9):1413–1424. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26160070. Accessed 23 Feb 2021.
- Ebrahimi-Fakhari D, Saffari A, Wahlster L, et al. Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep [Internet]. 2016 Oct 18;17(4):1053–1070. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27760312. Accessed 22 Apr 2021.
- Saffari A, Brosse I, Wiemer-Kruel A, et al. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. Orphanet J Rare Dis [Internet]. 2019 May 3;14(1):96. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31053163. Accessed 22 Apr 2021.
- von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet [Internet]. 2007 Oct 20;370(9596):1453–1457. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18064739. Accessed 7 Dec 2020.
- Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature [Internet]. 2020 May;581(7809):434–443. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32461654. Accessed 4 Mar 2021.
- South A. Rworldmap: a new r package for mapping global data. R J [Internet]. 2011;3(1):35–43. Available from: https://journal.r-project.org/archive/2011-1/RJournal_2011-1_South.pdf. Accessed 20 Jan 2021.
- Hardin AP, Hackell JM, Committee On P, et al. Age limit of pediatrics. Pediatrics [Internet]. 2017 Sep:140(3). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28827380. Accessed 6 Dec 2020.